1. Market Research
  2. > Pharmaceutical Market Trends
GLOBAL OPIOID INDUCED CONSTIPATION DRUG MARKET FORECAST 2017-2025

GLOBAL OPIOID INDUCED CONSTIPATION DRUG MARKET FORECAST 2017-2025

  • September 2017
  • 125 pages
  • ID: 5039888
  • Format: PDF
  • By Inkwood Research

Summary

Table of Contents

KEY FINDINGS
Global Opioid-Induced Constipation (OIC) drug market is estimated to grow at a CAGR of 7.08% during the forecast period of 2017 – 2025. The major drivers responsible for the market growth include the growing use of opioid, rising geriatric population, growing opioid prescription in North America and Europe, detection of safety threats and the easy availability of improved and effective OIC drugs. Some of the commonly prescribed opioids are Percocet, Vicodin, and codeine.

MARKET INSIGHTS
The global Opioid-Induced Constipation (OIC) drug market segments include drug type and prescription type. The drug types are further classified into Methyl naltrexone Bromide, Naloxegol, and Lubiprostone. The prescription types are further classified into prescribed and over the counter. Of these, the Over the counter segment is dominating the market as a doctor’s prescription is not required to buy the drugs which make its access much easier.

REGIONAL INSIGHTS
Geographically, the global opioid-induced constipation (OIC) market encompasses regions like the North America, Asia Pacific, Europe and Rest of World. Of these, the North American market is expected to dominate the global OIC drugs market during the forecast period on account of the fact that approximately 50% of the population is suffering from OIC. The countries in this region also have the most developed healthcare systems and medical devices industry in the world. The Federal agencies and private firms are equally supporting the market by providing access to the best medical facilities to the consumers. Growing lifestyle oriented diseases, increase in healthcare spending and technological advancement in cardiology are the factors responsible for the growth of this market.

COMPETITIVE INSIGHTS
Product launch is the key strategy adopted by the various market players of global opioid-Induced Constipation (OIC) drug market. The players are also engaging in partnerships, mergers, and acquisitions to withhold their stand in the market. For example, Ironwood Pharmaceuticals Inc entered into an agreement with Bionomics Limited in the year 2016 to fund their drug discovery processes.

In April 2017, Finch Therapeutics and Takeda Pharmaceutical Company Limited signed a collaboration to develop FIN-524, a live biotherapeutic product which is currently at the preclinical research stage. Some of the other pioneering companies for this market include Daiichi Sankyo Co Ltd, Pfizer, Progenics Pharmaceuticals Inc, Shionogi & Co Ltd, Allergan Plc, Nektar Therapeutics, Purdue Pharma L.P, S.L.A. Pharma Ag, Mundipharma International Limited, Ono Pharmaceutical Co., Ltd, Takeda Pharmaceutical Company Limited, Theravance Biopharma Inc, Valeant Pharmaceuticals International, Cosmo Pharmaceuticals Sa, Daewoong Pharmaceutical Co., Ltd and C.B. Fleet Company Inc.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
15% Off

($2565)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Muscle Atrophy - Pipeline Review, H2 2019

Muscle Atrophy - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Muscle Atrophy - Pipeline Review, H2 2019SummaryThis latest Pharmaceutical and Healthcare disease pipeline guide Muscle Atrophy - Pipeline Review, H2 2019, provides an overview of the Muscle Atrophy ( ...

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2019

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2019SummaryThis latest Pharmaceutical and Healthcare disease pipeline guide B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2019, provides ...

Osteomyelitis - Pipeline Review, H2 2019

Osteomyelitis - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Osteomyelitis - Pipeline Review, H2 2019SummaryPharmaceutical and Healthcare disease pipeline guide Osteomyelitis - Pipeline Review, H2 2019, provides an overview of the Osteomyelitis (Infectious Disease) ...


ref:plp2017

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on